Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-08-20
1998-04-14
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 530399, 424520, 514801, 514 12, A61K 3818, A61K 3822
Patent
active
057391130
ABSTRACT:
A composition and method are provided that are effective in revitalizing scar tissue by introducing a bioactive substance having angiogenic activity into the scar tissue. The bioactive substance can be introduced by itself, or it can be introduced into the scar tissue in a timed release form. The present invention is effective in treating stress urinary incontinence or localized muscular dysfunction.
REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 4061731 (1977-12-01), Gottlieb
patent: 4167945 (1979-09-01), Gottlieb
patent: 4191751 (1980-03-01), Gottlieb
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4703108 (1987-10-01), Silver et al.
patent: 4760131 (1988-07-01), Sundsmo et al.
patent: 4774091 (1988-09-01), Yamahira et al.
patent: 4810693 (1989-03-01), Pickart
patent: 4840940 (1989-06-01), Sottiurai
patent: 4849141 (1989-07-01), Fujioka et al.
patent: 4947840 (1990-08-01), Yannas et al.
patent: 4952403 (1990-08-01), Vallee et al.
patent: 4952404 (1990-08-01), Vallee et al.
patent: 5035887 (1991-07-01), Antoniades et al.
patent: 5073378 (1991-12-01), Shoshan et al.
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5219576 (1993-06-01), Chu et al.
patent: 5258028 (1993-11-01), Ersek
patent: 5428022 (1995-06-01), Palefsky et al.
patent: 5457093 (1995-10-01), Cini et al.
patent: 5470829 (1995-11-01), Prisell et al.
patent: 5480644 (1996-01-01), Freed
Martin 1979 Endocinphysiology Oxford pp. 107-108.
Brunt, et al 1988 Biotechnology 6:25-30.
Knighton, D.R. et al., "Wound Healing Angiogenesis: Indirect Stimulation by Basic Fibroblast Growth Factor," J. Trauma, vol. 30, pp. 134-144 (Dec. 1990).
Gore, D.C. et al., "Effect of Exogeneous Growth Hormone on Whole-Body and Isolated-Limb Protein Kinetics in Burned Patients," Arch. Surg., vol. 126, pp. 38-43 (Jan. 1991).
Reilly, W. et al., "Matrix Control of Turner Angiogenesis," Adv. Exp. Med. and Biol., vol. 242, pp. 221-227 (1988).
Fajardo, L.F. et al., "Methods in Laboratory Investigation: The Disc Angiogenesis System," Lab. Invest., vol. 58, pp. 718-724 (Jun. 1988).
Cooper, M.L. et al., "Use of a Composite Skin Graft Composed of Cultured Human Keratinocytes and Fibroblasts and a Collagen-GAG Matrix to Cover Full-Thickness Wounds on Athymic Mice," Surgery, vol. 109, pp. 198-207 (Feb. 1991).
Benharroch, D. et al., "Biology of the Fibroblast Growth Factor Gene Family," Isr. Med. Sci., vol. 26, pp. 212-219 (Apr. 1990).
Grotendorst, G.R. et al., "EGF and TGF-alpha are Potent Chemoattractants for Endothelial Cells and EGF-like Peptides are Present at Site of Tissue Regeneration," J. Cell Physio., vol. 139, pp. 617-623 (Jun. 1989).
Mahadevan, V. et al., "Factors Influencing Blood Supply in Wound Granuloma Quantitated by a New in Vivo Technique," Cancer Res., vol. 49, pp. 415-419 (Jan. 15, 1989).
Hansson, H.A. et al., "Transient Expression of Insulin-like Growth Factor I Immunoreactivity by Vascular Cells During Angiogenesis," Exp. Mole. Path., vol. 50, pp. 125-138 (Feb. 1989).
Hockel, M. et al., "Purified Monocyte-Derived Angiogenic Substance (Angiotropin) Induces Controlled Angiogenesis Associated with Regulated Tissue Proliferation in Rabbit Skin," J. Clin. Invest., vol. 82, pp. 1075-1090 (Sep. 1988).
Clark, R.A., "Cutaneous Tissue Repair: Basic Biologic Considerations," J. Am. Academy Dermat., vol. 13, pp. 701-725 (Nov. 1985).
Laato, M., "Effect of Epidermal Growth Factor (EGF) on Blood Flow and Albumin Extravasation in Experimental Granulation Tissue," Acta. Chir. Scand., vol. 152, pp. 401-405 (1986).
Savage, K., Ph.D., "The Effect of Platelet-Derived Growth Factor on Cell Division and Glycosaminoglycan Synthesis by Human Skin and Scar Fibroblasts," The J. Invest. Derm., vol. 89, pp. 93-99 (1987).
Pierce, G.F. et al., "Platelet-derived Growth Factor (BB Homodimer), Transforming Growth Factor-B1, and Basic Fibroblast Growth Factor in Dermal Wound Healing," Am. J. Path., American Association of Pathologists, vol. 140, No. 6, pp. 1375-1388 (Jun. 1992).
Tsuboi, R. et al., "Recombinant Basic Fibroblast Growth Factor Stimulates Wound Healing in Healing-Impaired db/db Mice," J. Exp. Med., The Rockefeller University Press, vol. 172, pp. 245-252 (Jul. 1990).
Valette, G. et al., "Une Nouvelle Methode d'Assai Des Traitments Cicatrisant Fondee Sur La Mise En Oeuvre D'une Plaie Experimentals Dont La Cicatrisation Est Artificiellement Pertubee par Hyperstimulation Locale Du Tissue De Granulation," Arzneimittelforschung, vol. 19, No. 7, pp. 1121-1132 (1969).
Martin, C.R., PhD., Textbook of Endocrine Physiology, Oxford University Press, New York, pp. 107-108 (1979).
Brunt et al., "Growth Factors Speed Wound Healing," Biotechnology, vol. 6, No. 1, pp. 25-30 (Jan. 1988).
Pesheva, P. et al., "Tenascin-R(J1 160-180)Inhibits Fibronectin-Mediated Cell Adhesion-Functional Relatedness to Tenascin-C," Journal of Cell Science, vol. 107, No. 8, pp. 2323-2333 (1994).
Mardon, H.J. et al., "The Role of the Ninth and Tenth Type III Domains of Human Fibronectin in Cell Adhesion," Federation of European Biochemical Societies Letters, vol. 340, No. 3 1994.
Dzamba, B.J. et al., "Substrate-Specific Binding of the Amino Terminus of Fibronectin to An Integrin Complex in Focal Adhesions," Journal of Biological Chemistry, vol. 269, No. 30 (1994).
Qian, J.J. et al., "Increased Cell Attachment, Migration and Differentiation on Hydroxyapatitee in the Presence of Collagen-Analog," Transitions of the Society for Biomaterials, vol. 126 (1994).
Bhatnagar, R.S. et al., "Design of Collagen-Mimetic Biomaterials," Transitions of the Society for Biomaterials, vol. 309 (1994).
English Translation of PCT #WO 93/12801.
Hennick et al., "Covalently Bound Conjugates and Albumin and Heparin: Synthesis, Fractionation and Characterization," Throm. Res., vol. 29, pp. 1-13, 1983.
Davis, S.S. et al., eds., Microspheres and Drug Therapy, Pharmaceutical, Immunological and Medical Aspects, Elsevier, Amsterdam, pp. 75-89, 1984.
Maciag, T., Molecular and Cellular Mechanisms of Angiogenesis, Important Adv. Oncol., pp. 85-98, 1990.
Savage et al. 1987. J. Invest. Derm. 89(1): p. 93.
C. R. Bard Inc.
Sayala Chhaya D.
LandOfFree
Compositions and method for revitalizing scar tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and method for revitalizing scar tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method for revitalizing scar tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-634627